Triglyceride-glucose index promising predictor of risk of gallstone, suggests study
A new study published in the Nature Science Reports showed that triglyceride-glucose (TyG) index is helpful in determining whether people are more likely to develop gallstone disease (GSD). The common gastrointestinal condition, gallstones affect 10% to 15% of persons worldwide, where this disease affects 10% to 20% of Americans, and the percentage is rising.
Cholecystitis, cholangitis, and gallbladder cancer are among the complications that might affect 3% to 8% of people with gallstones. These issues can occasionally even be fatal and can have major repercussions. According to earlier studies, diabetes, kidney stones, coronary heart disease, and other conditions are all closely linked to an elevated TyG index.
Triglycerides and fasting blood glucose are two biomarkers that are used in the TyG index to quantify insulin resistance (IR) and evaluate insulin sensitivity in the human body. So, Hongliang Li and colleagues used data from the National Health and Nutrition Examination Survey (NHANES) that spanned from 2017 to 2020 to look into the relationship between gallstones and the TyG index.
This objective of this survey was to evaluate the current state of health of the Americans. Every NHANES program participant gave their informed consent and freely took part in the study. In this study, subgroup analysis, logistic regression analysis, smooth curve fitting, and participant characteristics were used to assess the association between TyG index and gallstones.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.